Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA3C2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,876
Award facts
- Contract value 100% obligated
- $24,876.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24.88K to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count packages) on January 21, 2026, with a completion date of February 11, 2026. This non-set-aside, firm fixed-price delivery order was executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.99M through December 2026), which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is listed as Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which also holds a separate Indefinite Delivery Contract with the Defense Logistics Agency valued at up to $999.99M through December 2031. Both the prime contractor and parent company have demonstrated significant capability in fulfilling competitive federal contracts for diverse pharmaceutical products across multiple therapeutic domains, including oncology, diabetes management, neurological treatments, and pain management medications. This delivery order for TAGRISSO, an oncology medication, reflects the company's ongoing role as a critical vendor in the federal pharmaceutical supply chain serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA3C2?
SPE2DR26FA3C2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FA3C2 worth?
The government has obligated $24,876 on SPE2DR26FA3C2.
Is contract SPE2DR26FA3C2 an order under another contract?
Yes. SPE2DR26FA3C2 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3C2 competed?
The extent of competition for SPE2DR26FA3C2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award